Optical biopsies... Here to stay. Do not invest based on

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Optical biopsies... Here to stay.

Do not invest based on the information contained in this post or any post as doing so may cause substantial cash losses. This is not investment advice.

Some thoughts. If you think Spectrascience is the only company enlightened by the countless benefits of optical biopsies... think again.

Quote:
The success of that first human study led Precision Biopsy to focus on developing its next-generation product, the ClariCore Optical Biopsy System ™, as it prepares for global commercialization... used in prostate biopsy procedures

http://www.alliedminds.com/announcements/prec...w-facility

The company which designed this technology for prostate cancer is a subsidiary of Allied Minds which has a current share price of $384 per share . In the case of the WavSTAT, PENTAX is working with Spectrascience. Huge corporations are catching on to the future of optical biopsies. If there was no possible future, they wouldn't be wasting their time and money.

Do not invest based on the information contained in this post or any post as doing so may cause substantial cash losses. This is not investment advice.

Every day, more and more companies are seeing the benefits of 'real-time tissue classification'. I believe the medical community is at an important crossroads in history. As of this post, I believe within the next 3 to 5 years (possibly sooner), Spectascience will become a subsidiary of either PENTAX or Olympus (pure opinion and not investment advice).

I think companies who do not understand the benefits of optical biopsies, who continue to invest solely in standard biopsy procedures, and refuse to keep up with technological progress, will ultimately fail .

Thomas Watson, chairman of IBM in 1943 once said,
Quote:
I think there is a world market for maybe five computers.


Naysayers always.. ALWAYS win during the present time because they know no one can prove them wrong for the time being.

William Thomson said in 1899..
Quote:
Radio has no future.


For myself, the miniscule risk I am taking right now being invested in Spectrascience is completely outweighed by the possible, and in my opinion, probable success of the technology. If SCIE fails, no big deal, I didn't invest more than I can afford to lose. I don't try to 'buy on the dips', and I don't focus on individual red days. But if and when we see a 10Q with sales of over $100,000, it will only further enhance my belief that we are on the road to success.

Do not invest based on the information contained in this post or any post as doing so may cause substantial cash losses. This is not investment advice.

There are two areas I believe will be largest investment wins of our time; Optical Biopsies and 3D printing. Hey, I could be wrong- but just like today we say, "Man if only I could have invested in Apple December 12, 1980 I'd be rich!", in 20 years future investors are going to wish they had invested in optical biopsy and 3D printing companies. Time will tell.

As usual, do NOT invest based on this post. Everyone has the ability to sell their positions at any time, and no one is stopping you from selling. Only you can decide when you should buy, hold, and sell. Do your own DD.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 196

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 19

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Principle Health Expands Missouri, Illinois Imaging Services

Updated Category News Views 84

Diving Deeper into Principle's Strategic Move Principle Health Systems just took a sizable step by acquiring assets from a mobile diagnostic imaging company around St. Louis. Now they're elbow-deep into Missouri and Illinois, beefing up their ability to deliver bedside X-rays, ultrasounds, and EKGs straight to the patients in long-term care facilities. It ain't just about...

Continue Reading
Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Updated Category News Views 73

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Continue Reading
TCL Powers Senegal's Youth Olympics with Solar Display

Updated Category News Views 96

Innovative Display Tech Lands in Senegal Cutting through the noise of corporate clutter, TCL just made a move in Senegal that's got layers deeper than a PR stunt. They’ve handed over an ultra-low-power display system to the Université Amadou Mahtar Mbow (UAM) in Dakar, which is also moonlighting as the Youth Olympic Village for the 2026 Games. This isn't just any...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 101

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 96

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 105

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 106

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation of iRobot Corporation Sparks Legal Interest

Updated Category News Views 122

Understanding the Investigation into iRobot Corporation Recently, the national securities law firm Faruqi & Faruqi, LLP has begun investigating potential claims on behalf of shareholders of iRobot Corporation (NASDAQ: IRBT). This investigation has been prompted by concerns regarding the company’s financial disclosures and business strategies. Who Should be Concerned? If...

Continue Reading
Congruence Therapeutics Celebrated as a Fierce Leader in 2025

Updated Category News Views 125

Congruence Therapeutics Recognized in the Fierce 15 for 2025 Congruence Therapeutics, a biotechnology firm dedicated to innovative treatments for diseases linked to protein misfolding, recently celebrated a significant distinction as one of the Fierce 15 biotechnology companies for the year 2025. This esteemed accolade from Fierce Biotech highlights Congruence as one of...

Continue Reading
Transforming Trade Shows: The ExpoGroup Launches ExpoPortal

Updated Category News Views 190

Transforming the Exhibitor Experience with Innovation The Expo Group has unveiled its exciting new platform, ExpoPortal, aimed at enhancing the trade show experience for exhibitors. This innovative solution replaces their previous online system, CyberServices, which served its purpose well but has now been revitalized to meet the modern needs of exhibitors across various...

Continue Reading
Exploring Growth in the IoT Identity Access Management Sector

Updated Category News Views 103

Understanding the IoT Identity and Access Management Market In recent years, the IoT identity and access management market has become a focal point for businesses aiming to bolster their security measures in an increasingly digital world. Current reports indicate that the market is expected to see a remarkable growth trajectory, elevating from USD 5.44 billion in the...

Continue Reading
Major Insider Purchase by Christopher L Mapes at Nordson

Updated Category News Views 130

Significant Insider Purchase at Nordson In a notable move within the corporate landscape, Christopher L Mapes, who serves as the Director at Nordson (NASDAQ: NDSN), recently made a considerable investment in the company. According to recent filings, Mapes purchased 930 shares of Nordson, amounting to an impressive total of $215,713. This proactive step signals a strong...

Continue Reading